Furosemide Injection, Solution
Product Images NDC 51662-1336

9 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 51662-1336). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Labeling (1336 1 Serialized Labeling)

Serialized Labeling (1336 1 Serialized Labeling)
Furosemide Injection USP 10 mg/mL, 4 mL single-use vial for intramuscular or intravenous use. The amber glass vial has an orange cap and a label showing the product name, strength, dosage form, and use instructions. Distributed by HF Acquisition Co LLC.*
FDA Label Image

5166213362 Label

5166213362 Label
Label for FUROSEMIDE Injection USP 40 mg/4 mL (10 mg/mL) in a 4 mL vial. The label includes NDC 51662-1336-2, lot number, and expiration date. Distributed by HF Acquisition Co LLC, DBA HealthFirst. Intended for intravenous or intramuscular use.*
FDA Label Image

5166213363 Rfid Label

5166213363 Rfid Label
Small white rectangular label featuring a GS1 DataMatrix barcode on the upper right and multiple numeric identifiers on the left. Text includes reference to manufacturer package insert and distributor information for HF Acquisition Co., LLC, Mukilteo, WA 98275. The label is affixed on a transparent surface with a gray border.*
FDA Label Image

5166213363 Label

5166213363 Label
Label for FUROSEMIDE Injection USP 40 mg/4 mL (10 mg/mL) in a 4 mL vial, box of 25. The label includes NDC 51662-1336-3, lot number, expiration date 2021-06-01, and storage instructions. Distributed by HF Acquisition Co LLC, Mukilteo, WA. The product is for intravenous or intramuscular use and is prescription only (Rx Only).*
FDA Label Image

How Supplied (How Supplied)

How Supplied (How Supplied)
A data table listing unit of sale and concentration information for various FUROSEMIDE injection solutions, including NDC numbers, carton sizes (e.g., containing 25 vials), and bundle sizes (e.g., containing 10 ANSYR syringes), with concentrations noted as 10 mg/mL and corresponding total dosages per vial or syringe volumes.*
FDA Label Image

Logo (Logo How Supplied)

FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Furosemide showing its molecular arrangement with a benzene ring, sulfonamide, carboxylic acid, chlorine, and a furan group. The diagram is a black-and-white line drawing illustrating the chemical bonds and substituents.*
FDA Label Image

Vial (Vial Label)

Vial (Vial Label)
Furosemide Injection, USP 10 mg/mL (40 mg/4 mL) single-use vial label. The label indicates it is for intravenous or intramuscular use and includes handling instructions such as avoiding use if the solution is discolored or contains particulates. The label features the Hospira, Inc. logo and details, along with barcodes and lot/expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.